Even asymptomatic COVID-19 could lead to long-term damage - study
New research from Cedars-Sinai is the first to report not only the presence of elevated autoantibodies after mild or asymptomatic infection, but their persistence over time.
People queue at Westminster Bridge to receive COVID-19 vaccine and booster doses, as the spread of the coronavirus disease (COVID-19) continues, at a walk-in vaccination centre at Saint Thomas' Hospital in London, Britain, December 14, 2021.(photo credit: REUTERS/TOBY MELVILLE)ByJERUSALEM POST STAFFUpdated:
